What is the latest GMP of M.K.Sons Fine Jewels IPO today?
As of 03 November 2026, the latest Grey Market Premium (GMP) for M.K.Sons Fine Jewels IPO is ₹6.5 (+4.0%). Based on the upper price band of ₹162.00, the expected listing price is ₹168.50, indicating an estimated listing profit of ₹591 per lot (📈 Positive Listing).
What are the opening, closing, and allotment dates for M.K.Sons Fine Jewels IPO?
M.K.Sons Fine Jewels IPO opens for subscription on 28-Oct and closes on 30-Oct. The Basis of Allotment (BOA) will be finalized on 2-Nov. Refunds/mandate unblocking begins on 3-Nov, shares will be credited to Demat by 3-Nov, and stock exchange listing is scheduled for 4-Nov on NSE/BSE.
What is the minimum lot size and investment amount for M.K.Sons Fine Jewels IPO?
The minimum lot size for M.K.Sons Fine Jewels IPO is 91 equity shares. At the upper price band of ₹162.00, a retail investor requires a minimum investment of ₹14,742.00. Retail investors can apply for up to 13 lots (₹191,646.00), while small HNI (sHNI) bids start from 14 lots (₹206,388.00).
How can I check M.K.Sons Fine Jewels IPO allotment status online?
Investors can check the official allotment status of M.K.Sons Fine Jewels IPO on TradeRight's live Allotment Radar or directly on the official registrar portal (Link Intime / KFintech). You only need your PAN card number or Application number to view whether shares have been allotted to your Demat account.
What is the subscription status of M.K.Sons Fine Jewels IPO?
M.K.Sons Fine Jewels IPO has registered an overall subscription multiple of 5.09x with strong demand across Retail Individual Investors (RII), Non-Institutional Investors (NII), and Qualified Institutional Buyers (QIB). TradeRight monitors real-time bid quantities directly from the BSE and NSE bidding engines.
Should I apply for M.K.Sons Fine Jewels IPO for listing gains or long-term?
TradeRight's multi-factor investment committee has rated M.K.Sons Fine Jewels with an AI Score of 65/100 (BALANCED / NEUTRAL). Heavy Oversubscription (5.09x) supports potential listing gains, while audited 3-year financials and return on equity (15%) offer fundamental backing for long-term investors.